Cargando…
Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
Breviscapine (BVP), a flavonoid compound, is widely used in the treatment of cardiovascular and cerebrovascular diseases; however, the low oral bioavailability and short half-life properties limit its application. The aim of this study was to investigate the three preparations for improving its oral...
Autores principales: | Song, Zilin, Yin, Jiaojiao, Xiao, Peifu, Chen, Jin, Gou, Jingxin, Wang, Yanjiao, Zhang, Yu, Yin, Tian, Tang, Xing, He, Haibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909566/ https://www.ncbi.nlm.nih.gov/pubmed/33498470 http://dx.doi.org/10.3390/pharmaceutics13020132 |
Ejemplares similares
-
Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder
por: Zhang, Ting, et al.
Publicado: (2022) -
Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021) -
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
por: Chen, Yingchong, et al.
Publicado: (2020) -
Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability
por: Thadkala, Kiran, et al.
Publicado: (2014) -
Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
por: Li, Jun, et al.
Publicado: (2018)